Published in Pulm Circ on January 01, 2011
Bone Morphogenetic Protein Receptor Type II Deficiency and Increased Inflammatory Cytokine Production. A Gateway to Pulmonary Arterial Hypertension. Am J Respir Crit Care Med (2015) 1.53
The adventitia: essential regulator of vascular wall structure and function. Annu Rev Physiol (2012) 1.31
Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol (2011) 1.25
Metabolomic analysis of bone morphogenetic protein receptor type 2 mutations in human pulmonary endothelium reveals widespread metabolic reprogramming. Pulm Circ (2012) 1.19
A potential role for insulin resistance in experimental pulmonary hypertension. Eur Respir J (2012) 1.16
Idiopathic and heritable PAH perturb common molecular pathways, correlated with increased MSX1 expression. Pulm Circ (2011) 1.00
Identification of a common Wnt-associated genetic signature across multiple cell types in pulmonary arterial hypertension. Am J Physiol Cell Physiol (2014) 0.98
BMPR2 preserves mitochondrial function and DNA during reoxygenation to promote endothelial cell survival and reverse pulmonary hypertension. Cell Metab (2015) 0.92
Increased Mutagen Sensitivity and DNA Damage in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med (2015) 0.89
Connectivity map analysis of nonsense-mediated decay-positive BMPR2-related hereditary pulmonary arterial hypertension provides insights into disease penetrance. Am J Respir Cell Mol Biol (2012) 0.88
BMP pathway regulation of and by macrophages. PLoS One (2014) 0.85
Rescuing the BMPR2 signaling axis in pulmonary arterial hypertension. Drug Discov Today (2014) 0.84
Hyperoxia synergizes with mutant bone morphogenic protein receptor 2 to cause metabolic stress, oxidant injury, and pulmonary hypertension. Am J Respir Cell Mol Biol (2013) 0.84
A process-based review of mouse models of pulmonary hypertension. Pulm Circ (2012) 0.82
Accumulation of isolevuglandin-modified protein in normal and fibrotic lung. Sci Rep (2016) 0.81
Expression of mutant bone morphogenetic protein receptor II worsens pulmonary hypertension secondary to pulmonary fibrosis. Pulm Circ (2015) 0.80
Redox biology in pulmonary arterial hypertension (2013 Grover Conference Series). Pulm Circ (2015) 0.79
Role of oxidized lipids in pulmonary arterial hypertension. Pulm Circ (2016) 0.77
Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects. Eur Respir J (2017) 0.77
Antagonism of the thromboxane-prostanoid receptor is cardioprotective against right ventricular pressure overload. Pulm Circ (2016) 0.76
Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension. PLoS One (2016) 0.76
BMPR2 spruces up the endothelium in pulmonary hypertension. Protein Cell (2015) 0.75
Reactive Oxygen and Nitrogen Species in the Development of Pulmonary Hypertension. Antioxidants (Basel) (2017) 0.75
Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertension. Pulm Circ (2017) 0.75
Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A (2001) 68.44
Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (2009) 49.82
The Gene Ontology in 2010: extensions and refinements. Nucleic Acids Res (2009) 11.49
GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies. BMC Bioinformatics (2004) 11.23
Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat Genet (2000) 7.20
A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases. Anal Biochem (1997) 5.23
Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation (2010) 3.72
Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest (2009) 3.53
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. Br J Cancer (2008) 3.39
Clinical review: The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab (2008) 3.00
Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1. J Cell Biol (2003) 2.51
Alterations of cellular bioenergetics in pulmonary artery endothelial cells. Proc Natl Acad Sci U S A (2007) 2.44
Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer. Am J Physiol Heart Circ Physiol (2007) 2.26
Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med (2008) 2.15
Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress. Methods Enzymol (2007) 1.98
Regulation of reactive oxygen species and genomic stability in hematopoietic stem cells. Antioxid Redox Signal (2008) 1.86
Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension. Hum Mol Genet (2002) 1.85
Controlling cell fate by bone morphogenetic protein receptors. Mol Cell Endocrinol (2003) 1.67
Redox signaling (cross-talk) from and to mitochondria involves mitochondrial pores and reactive oxygen species. Biochim Biophys Acta (2010) 1.60
Phosphorylation of endothelial nitric-oxide synthase regulates superoxide generation from the enzyme. J Biol Chem (2008) 1.55
Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling? Proc Am Thorac Soc (2006) 1.53
Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions. Am J Physiol Lung Cell Mol Physiol (2008) 1.47
Gross BMPR2 gene rearrangements constitute a new cause for primary pulmonary hypertension. Genet Med (2005) 1.45
Detection of superoxide in vascular tissue. Arterioscler Thromb Vasc Biol (2002) 1.44
Short-term calorie restriction reverses vascular endothelial dysfunction in old mice by increasing nitric oxide and reducing oxidative stress. Aging Cell (2010) 1.41
NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions. Curr Pharm Des (2006) 1.31
Molecular effects of loss of BMPR2 signaling in smooth muscle in a transgenic mouse model of PAH. Am J Physiol Lung Cell Mol Physiol (2007) 1.25
Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension. Respir Res (2009) 1.24
Inhibitors of lactate dehydrogenase isoforms and their therapeutic potentials. Curr Med Chem (2010) 1.22
Redox regulation of lung inflammation: role of NADPH oxidase and NF-kappaB signalling. Biochem Soc Trans (2007) 1.18
A proposed mitochondrial-metabolic mechanism for initiation and maintenance of pulmonary arterial hypertension in fawn-hooded rats: the Warburg model of pulmonary arterial hypertension. Adv Exp Med Biol (2010) 1.08
Cross talk between Smad, MAPK, and actin in the etiology of pulmonary arterial hypertension. Adv Exp Med Biol (2010) 1.05
In vivo measurement of proximal pulmonary artery elastic modulus in the neonatal calf model of pulmonary hypertension: development and ex vivo validation. J Appl Physiol (1985) (2010) 1.04
Isoketals: highly reactive gamma-ketoaldehydes formed from the H2-isoprostane pathway. Chem Phys Lipids (2004) 1.03
Structural implications of mitochondrial dynamics. Biotechnol J (2008) 1.03
Isofurans: novel products of lipid peroxidation that define the occurrence of oxidant injury in settings of elevated oxygen tension. Antioxid Redox Signal (2005) 1.03
Cross-talk between the bone morphogenetic protein pathway and other major signaling pathways results in tightly regulated cell-specific outcomes. FEBS J (2007) 1.00
BMPR2 mutations have short lifetime expectancy in primary pulmonary hypertension. Hum Mutat (2005) 0.90
Targeting the Warburg effect in hematological malignancies: from PET to therapy. Curr Opin Oncol (2009) 0.89
Oxidant stress but not thromboxane decreases with epoprostenol therapy. Free Radic Biol Med (2005) 0.88
Bringing down the ROS: a new therapeutic approach for PPHN. Am J Physiol Lung Cell Mol Physiol (2008) 0.87
Evidence that the E2-isoprostane, 15-E2t-isoprostane (8-iso-prostaglandin E2) is formed in vivo. J Lipid Res (1998) 0.84
Insight into redox-regulated gene networks in vascular cells. Bioinformation (2007) 0.83
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61
The functional spectrum of low-frequency coding variation. Genome Biol (2011) 4.42
Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med (2006) 3.59
Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations. Free Radic Biol Med (2011) 3.58
Association between cell-free hemoglobin, acetaminophen, and mortality in patients with sepsis: an observational study. Crit Care Med (2013) 3.30
American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers. J Clin Oncol (2014) 3.07
Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy. Free Radic Biol Med (2006) 3.04
The relationship between distance to hospital and patient mortality in emergencies: an observational study. Emerg Med J (2007) 2.87
Isoprostanes: markers and mediators of oxidative stress. FASEB J (2004) 2.83
Association of the metabolic syndrome with pulmonary venous hypertension. Chest (2009) 2.75
Quantifying changes in the thiol redox proteome upon oxidative stress in vivo. Proc Natl Acad Sci U S A (2008) 2.65
Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer Inst (2002) 2.45
Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice. Am J Respir Crit Care Med (2002) 2.17
Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension. Circ Cardiovasc Genet (2012) 2.16
Lipid peroxidation in aging brain and Alzheimer's disease. Free Radic Biol Med (2002) 2.08
EIF2AK4 mutations in pulmonary capillary hemangiomatosis. Chest (2014) 1.88
First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001). J Infect Dis (2012) 1.87
Methicillin-resistant Staphylococcus aureus sterile-site infection: The importance of appropriate initial antimicrobial treatment. Crit Care Med (2006) 1.86
Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics (2009) 1.82
Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders. Hypertension (2005) 1.80
Outcomes of congenital diaphragmatic hernia in the modern era of management. J Pediatr (2013) 1.80
Exploring HIV stigma and quality of life for persons living with HIV infection. J Assoc Nurses AIDS Care (2009) 1.80
Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease. Ann Neurol (2002) 1.79
Oxidant injury occurs rapidly after cardiac arrest, cardiopulmonary resuscitation, and reperfusion. Crit Care Med (2005) 1.76
Age-associated epigenetic drift: implications, and a case of epigenetic thrift? Hum Mol Genet (2013) 1.76
PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ Heart Fail (2008) 1.75
Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases. J Biol Chem (2005) 1.73
High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension. Circ Heart Fail (2013) 1.70
Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels. Circ Res (2005) 1.70
Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E. Circ Res (2004) 1.68
Role of BMPR2 alternative splicing in heritable pulmonary arterial hypertension penetrance. Circulation (2012) 1.64
Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension. Proc Natl Acad Sci U S A (2002) 1.63
Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. Chem Phys Lipids (2004) 1.63
Transgenic mice overexpressing glutathione peroxidase 4 are protected against oxidative stress-induced apoptosis. J Biol Chem (2004) 1.60
Penetrance of pulmonary arterial hypertension is modulated by the expression of normal BMPR2 allele. Hum Mutat (2009) 1.60
Unrecognized glucose intolerance is common in pulmonary arterial hypertension. J Heart Lung Transplant (2011) 1.58
Surgical residents' knowledge of documentation and coding for professional services: an opportunity for a focused educational offering. Am J Surg (2007) 1.57
Immune activation caused by vascular oxidation promotes fibrosis and hypertension. J Clin Invest (2015) 1.55
Abacavir hypersensitivity reaction: an update. Ann Pharmacother (2008) 1.55
The in vivo gene expression signature of oxidative stress. Physiol Genomics (2008) 1.55
Embryonic growth-associated protein is one subunit of a novel N-terminal acetyltransferase complex essential for embryonic vascular development. Circ Res (2006) 1.54
Recommended joint and meta-analysis strategies for case-control association testing of single low-count variants. Genet Epidemiol (2013) 1.52
Endogenous lipoproteins impact the response to endotoxin in humans. Crit Care Med (2002) 1.51
Violence against nurses working in US emergency departments. J Nurs Adm (2009) 1.51
Reduction in glutathione peroxidase 4 increases life span through increased sensitivity to apoptosis. J Gerontol A Biol Sci Med Sci (2007) 1.47
Mass spectrometric quantification of F2-isoprostanes as indicators of oxidant stress. Methods Mol Biol (2002) 1.45
Association between prehospital time intervals and ST-elevation myocardial infarction system performance. Circulation (2010) 1.44
Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle. Am J Physiol Lung Cell Mol Physiol (2007) 1.42
Postoperative acute kidney injury is associated with hemoglobinemia and an enhanced oxidative stress response. Free Radic Biol Med (2011) 1.42
Inhalation of Stachybotrys chartarum evokes pulmonary arterial remodeling in mice, attenuated by Rho-kinase inhibitor. Mycopathologia (2011) 1.42
Effects of age and caloric restriction on lipid peroxidation: measurement of oxidative stress by F2-isoprostane levels. J Gerontol A Biol Sci Med Sci (2005) 1.41
Isoprostane generation and function. Chem Rev (2011) 1.41
Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension. Am J Respir Crit Care Med (2008) 1.38
Gene expression in BMPR2 mutation carriers with and without evidence of pulmonary arterial hypertension suggests pathways relevant to disease penetrance. BMC Med Genomics (2008) 1.37
Acetaminophen inhibits hemoprotein-catalyzed lipid peroxidation and attenuates rhabdomyolysis-induced renal failure. Proc Natl Acad Sci U S A (2010) 1.35
Insights into oxidative stress: the isoprostanes. Curr Med Chem (2007) 1.32
The association between prehospital endotracheal intubation attempts and survival to hospital discharge among out-of-hospital cardiac arrest patients. Acad Emerg Med (2010) 1.30
Tau isoform regulation is region- and cell-specific in mouse brain. J Comp Neurol (2008) 1.29
Single-chain fragment variable antibody piezoimmunosensors. Anal Chem (2005) 1.29
Molecular effects of loss of BMPR2 signaling in smooth muscle in a transgenic mouse model of PAH. Am J Physiol Lung Cell Mol Physiol (2007) 1.25
Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol (2011) 1.25
Characterization of an animal model of postmenopausal hypertension in spontaneously hypertensive rats. Hypertension (2002) 1.25
Plasma biomarkers of oxidant stress and development of organ failure in severe sepsis. Shock (2011) 1.24
The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation. Chem Phys Lipids (2004) 1.23
Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo. Proc Natl Acad Sci U S A (2010) 1.23
The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. Am J Respir Crit Care Med (2002) 1.22
Behavioral and neural correlates of perceived and imagined musical timbre. Neuropsychologia (2004) 1.21
N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial. Crit Care Med (2009) 1.20
Low-voltage-activated (T-type) calcium channels control proliferation of human pulmonary artery myocytes. Circ Res (2005) 1.19
Histone deacetylase inhibitor enhances recovery after AKI. J Am Soc Nephrol (2013) 1.19
Metabolomic analysis of bone morphogenetic protein receptor type 2 mutations in human pulmonary endothelium reveals widespread metabolic reprogramming. Pulm Circ (2012) 1.19
A potential role for insulin resistance in experimental pulmonary hypertension. Eur Respir J (2012) 1.16
Superoxide dismutase and oxidative stress in Dahl salt-sensitive and -resistant rats. Am J Physiol Regul Integr Comp Physiol (2002) 1.16
Modification of proteins by isoketal-containing oxidized phospholipids. J Biol Chem (2004) 1.15
Localization of isoketal adducts in vivo using a single-chain antibody. Free Radic Biol Med (2004) 1.15
Increased age reduces DAF-16 and SKN-1 signaling and the hormetic response of Caenorhabditis elegans to the xenobiotic juglone. Mech Ageing Dev (2009) 1.15
Evidence for right ventricular lipotoxicity in heritable pulmonary arterial hypertension. Am J Respir Crit Care Med (2014) 1.14
Disruption of bone morphogenetic protein receptor 2 (BMPR2) in mammary tumors promotes metastases through cell autonomous and paracrine mediators. Proc Natl Acad Sci U S A (2011) 1.14
Stability of measurements of biomarkers of oxidative stress in blood over 36 hours. Cancer Epidemiol Biomarkers Prev (2004) 1.14
The pathology of bleomycin-induced fibrosis is associated with loss of resident lung mesenchymal stem cells that regulate effector T-cell proliferation. Stem Cells (2011) 1.12
Treatment with a catalytic antioxidant corrects the neurobehavioral defect in ataxia-telangiectasia mice. Free Radic Biol Med (2004) 1.12
Oxidative stress measured by urine F2-isoprostane level is associated with prostate cancer. J Urol (2011) 1.11
Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension. Nat Genet (2013) 1.11
Effects of reactive gamma-ketoaldehydes formed by the isoprostane pathway (isoketals) and cyclooxygenase pathway (levuglandins) on proteasome function. FASEB J (2002) 1.11
Isoketals form cytotoxic phosphatidylethanolamine adducts in cells. J Lipid Res (2009) 1.10
Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer development. PLoS Med (2013) 1.10
The Diastolic Pressure Gradient Does Not-and Should Not-Predict Outcomes. JACC Heart Fail (2015) 1.10
Randomized, placebo-controlled trial of acetaminophen for the reduction of oxidative injury in severe sepsis: the Acetaminophen for the Reduction of Oxidative Injury in Severe Sepsis trial. Crit Care Med (2015) 1.10